Literature DB >> 14730361

The costimulation-regulated duration of PKB activation controls T cell longevity.

Jianxun Song1, Shahram Salek-Ardakani, Paul R Rogers, Mary Cheng, Luk Van Parijs, Michael Croft.   

Abstract

A brief antigenic stimulus can promote T cell proliferation, but the duration and nature of intracellular signals required for survival are unclear. Here we show that in the absence of OX40 costimulation, antigen-activated CD4+ cells are short-lived because the activity of protein kinase B (PKB; also known as Akt) is not maintained over time. Activated T cells that express a dominant-negative variant of PKB also undergo apoptosis, reproducing the OX40-deficient phenotype. In contrast, an active form of PKB prevents downregulation of antiapoptotic proteins in OX40-deficient T cells, rescues antigen-induced cell survival in vivo, and controls inflammation in recall responses. Thus, sustained and periodic PKB signaling has an integral role in regulating T cell longevity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730361     DOI: 10.1038/ni1030

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  72 in total

1.  New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.

Authors:  Xiang Xiao; Weihua Gong; Gulcin Demirci; Wentao Liu; Silvia Spoerl; Xiufeng Chu; D Keith Bishop; Laurence A Turka; Xian C Li
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

Review 2.  Signaling through OX40 enhances antitumor immunity.

Authors:  Shawn M Jensen; Levi D Maston; Michael J Gough; Carl E Ruby; William L Redmond; Marka Crittenden; Yuhuan Li; Sachin Puri; Christian H Poehlein; Nick Morris; Magdalena Kovacsovics-Bankowski; Tarsem Moudgil; Chris Twitty; Edwin B Walker; Hong-Ming Hu; Walter J Urba; Andrew D Weinberg; Brendan Curti; Bernard A Fox
Journal:  Semin Oncol       Date:  2010-10       Impact factor: 4.929

3.  The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection.

Authors:  Selma Tuzlak; Robyn L Schenk; Ajithkumar Vasanthakumar; Simon P Preston; Manuel D Haschka; Dimitra Zotos; Axel Kallies; Andreas Strasser; Andreas Villunger; Marco J Herold
Journal:  Cell Death Differ       Date:  2017-01-13       Impact factor: 15.828

4.  Protein transduction as a means of effective manipulation of Cdc42 activity in primary T cells.

Authors:  Irina Tskvitaria-Fuller; Neeta Mistry; Shining Sun; Christoph Wülfing
Journal:  J Immunol Methods       Date:  2006-12-08       Impact factor: 2.303

5.  IL-21 is required for CD4 memory formation in response to viral infection.

Authors:  Yuqing Yuan; Yiping Yang; Xiaopei Huang
Journal:  JCI Insight       Date:  2017-04-06

6.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

7.  Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.

Authors:  Takanori So; Pejman Soroosh; So-Young Eun; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

8.  Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells.

Authors:  Douglas V Dolfi; Alina C Boesteanu; Constantinos Petrovas; Dong Xia; Eric A Butz; Peter D Katsikis
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 9.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

10.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.